metformin has been researched along with Disease in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Disease: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.
Excerpt | Relevance | Reference |
---|---|---|
"Metformin is a safe, effective and useful drug for glucose management in patients with diabetes." | 2.66 | The Use of Metformin to Increase the Human Healthspan. ( Lushchak, O; Piskovatska, V; Storey, KB; Vaiserman, AM, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Piskovatska, V | 1 |
Storey, KB | 1 |
Vaiserman, AM | 1 |
Lushchak, O | 1 |
Kanigur Sultuybek, G | 1 |
Soydas, T | 1 |
Yenmis, G | 1 |
2 reviews available for metformin and Disease
Article | Year |
---|---|
The Use of Metformin to Increase the Human Healthspan.
Topics: Aged; Aging; Clinical Trials as Topic; Disease; Frailty; Humans; Longevity; Metformin | 2020 |
NF-κB as the mediator of metformin's effect on ageing and ageing-related diseases.
Topics: Aging; Animals; Disease; Humans; Metformin; Molecular Targeted Therapy; NF-kappa B | 2019 |